InsidersTradesSigma
Browse the detailed record of transactions filed by FLAVIN JOHN L, Director. Director active across 1 companies, notably Pyxis Oncology, Inc.. Cumulatively, 3 reports have been recorded. The latest transaction was disclosed on 31 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
John L. Flavin is a Board Member at Pyxis Oncology, Inc. He plays an active role in the governance of the company, bringing his expertise in biotechnology and strategy. Flavin contributes to important decision-making and the strategic direction of Pyxis Oncology.